|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent显示文摘 | Mendel D Laird A Smolich B | 2000 | Anti-Cancer Drug Des2000，15，1： | 1 |
| 2 | Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an antiangiogenesis agent 显示文摘 | MEDNEL D B LAIRD A D SMOLICH B D | 2000 | Anti Cancer Drug Res2000，15，1： | 1 |
| 3 | Left and right ventricular myocardial morphometry in fetal, neonatal, and adult sheep显示文摘 | Smolich JJ Walker AM Campbell GR | 1989 | Am J Physiol1989，257，12： | 1 |
| 4 | Comparison of effects of pravastatin and hormone therapy on soluble Pselectin and platelet P-selectin expression in postmenopausal hypercholesterolemic women显示文摘 | Peverill RE Smolich JJ Malan E | 2006 | Maturitas2006，53，2： | 1 |
| 5 | The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c -kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts显示文摘 | SMOLICH B D YUEN H A WEST K A | 2001 | Blood2001，97，5： | 1 |
| 6 | Development of SU5416, a selective small molecule inhibits of VEGF receptor tyrosine kirase activity, as an anti-angiogenesis agent显示文摘 | Mendel DB Laird AD Smolich BD | 2000 | AntiCancer Drug Design2000，15，1： | 1 |
| 7 | Development of Su5416 a selective Small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an angiogenesis agent显示文摘 | Mendel DB Laird AD Smolich BD | 2000 | J Anticancer Drug Des2000，15，1： | 1 |
| 8 | Effects of SU5416,a small molecule tyrosine kinase receptor inhibitor,on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia显示文摘 | OFARRELL A M YUEN H A SMOLICH B | 2004 | Leuk Res2004，28，7： | 1 |
| 9 | SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase 显示文摘 | Yee K W O'Farrell A M Smolich B D | 2002 | Blood2002，100，8： | 1 |
| 10 | Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent 显示文摘 | Mendel DB Laird AD Smolich BD | 2000 | Anticancer Drug Des2000，15，1： | 1 |
| 11 | Development of SU5416 ,a selective small molecule inhabitor of VEGF receptor tyrosine kinase activity ,as an anti-angiogenesis agent显示文摘 | Mendel D B Laird A D Smolich B D | 2000 | Anticancer Drug Res2000，15，1： | 1 |
| 12 | Enhanced central and conduit pulmonary arterial reservoir function offsets reduced ductal systol- ic outflow during constriction of the fetal ductus arteriosus 显示文摘 | Smolich JJ Penny DJ Mynard JP | 2012 | Am J Physiol Regul Integr Comp Physiol2012，302，1： | 1 |
| 13 | Development of SU5416,a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity,as an anti-angiogenesis agent显示文摘 | Laird AD Smolich BD | 2000 | Anticancer Drug Des2000，15，1： | 1 |
| 14 | Massive decline in lung liquid before vaginal delivery at term in the fetal lamb 显示文摘 | Berger PJ Kyriakldes MA Smolich JJ | 1998 | Am J Obstet Gynecol1998，178，2： | 1 |
| 15 | The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts显示文摘 | Smolich B D Yuen H A West K A | 2001 | Blood2001，97，5： | 1 |
| 16 | Development of SU5416,a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity,as an anti-angiogenesis agent显示文摘 | Laird AD Smolich BD | 2000 | Anticancer Drug Des2000，15，1： | 1 |
| 17 | Development of SU5416, A selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent 显示文摘 | Mendel DB Laird AD Smolich BD | 2000 | Anticancer Drug Des2000，15，1： | 1 |
| 18 | Urotensin-II contributes to pulmonary vasoconstriction in aperinatal model of persistent pulmonary hypertension ofthe newborn secondary to meconium aspiration syndrome显示文摘 | Simpson C M Smolich J J Shekerdemian L S | 2010 | Pediatr Res2010，67，2： | 1 |
| 19 | SU5416 and SU5614 inhibit kinase activity of wild-type and mutant Flt3 receptor tyrosine kinase显示文摘 | Yee KWH O' Farrell AM Smolich BD | 2002 | Blood2002，100，： | 1 |
| 20 | Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent 显示文摘 | Mendel DB Laird AD Smolich BD | 2000 | Anticancer Drug Des2000，15，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员